Delivery Order SPE2DB22D1041-SPE2DB24FUDM8

Award Date 8/30/24
Potential Completion Date 9/3/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,588.22, is for the delivery of amlodipine-valsartan 5-160 mg tablets in 30-count packages. The contract has an ultimate completion date of March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Amlodipine-Valsartan 10-160 mg tablets, with a ceiling value of $3,912.17 and a completion date of February 7, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,761.26 firm fixed-price contract is for the delivery of AMLODIPINE-VALSARTAN 5-320 MG 30S, a cardiovascular medication, and has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $1,161.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMLODIPINE-VALSARTAN 10-160 MG 30S medication. The contract has a completion date of June 6, 2025 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,656.50, is for the delivery of Amlodipine-Valsartan 10-160 mg tablets in quantities of 30 per bottle. This is a firm fixed-price delivery order contract with a performance period through July 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Amlodipine-Valsartan 5-160 mg tablets, a cardiovascular medication, with a ceiling value of $2,434.85 and a completion date of December 20, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,745.76, is for the delivery of AMLODIPINE-VALSARTAN 10-320 mg 30-count tablets. This is a firm fixed price delivery order contract with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMLODIPINE-VALSARTAN 10-320 MG 30S medication. The contract has a ceiling value of $6,967.58 and is a firm fixed-price delivery order with a completion date of June 10, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,003.77 firm fixed-price delivery order covers the supply of Amlodipine-Valsartan 10-320 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of 4,565,964,777 units of the pharmaceutical product Amlodipine-Valsartan 10-160 mg, with a ceiling value of $1,270.76. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 30, 2024. The contract does not have a set-aside designation. As a large...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUDM8
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $6,921.88 firm fixed-price contract is for the supply of Amlodipine-Valsartan 5-160 mg tablets. This order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to deliver critical medical commodities, including specialty medications, vaccines, and medical equipment, to various defense and civilian agencies. This specific contract order has no set-aside designation and is scheduled for completion by September 3, 2024.

Generated 11/29/24, 9:01 AM